Baby formula with extra ingredients may cut infections and boost growth
NCT ID NCT06137235
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether infant formula with added bioactive ingredients helps healthy babies grow well, tolerate the formula, and have fewer infections. About 456 full-term infants will receive either the test formula or a standard formula. Parents will report any infection symptoms and the babies' growth will be measured.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- infant formula with bioactive ingredients
- What this could lead to
- If it works, this could lead to a better infant formula that helps reduce common infections and supports healthy growth in babies.
- What could go wrong
- This is a relatively small, early-stage trial with no phase designation, so results may not be conclusive. The benefits over standard formula may be small or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROWTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harokopio University
Athens, Greece
-
International Hellenic University
Thessaloniki, Greece
-
University of Thessaly
Trikala, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
- Experimental malaria vaccine aims to block parasite growth
- Rare disease drug shows promise in reducing infections
- New rapid test for infection and inflammation put to the test
- Fast new swab test could speed up vaginitis diagnosis
- Scientists crack the code of antibiotic-friendly superbug